#hepatitis C treatment

The risk was lower in people who had achieved a sustained virological response compared with those who had not.

Despite limited testing and clinical visits, 95% of the study population was able to achieve a sustained virological response.

Hepatitis A and E usually resolve on their own, but hepatitis B and C can cause serious liver disease, including cirrhosis and liver cancer.

Premature discontinuation of hepatitis C treatment did not diminish the likelihood of sustained virological response.

The hep C mortality reduction goal will not be met by any state, according to recent projections.

Researchers found that longer usage of injection drugs was positively linked to hep C testing.

Requiring sobriety prior to treatment and curtailing harm reduction hinder efforts to eliminate hep C.

The blood-borne virus, which can lead to cirrhosis and liver cancer, remains a major global health threat.

Some state Medicaid programs and prison systems still restrict treatment based on substance use or stage of liver disease.

A recent study of the direct-acting antiviral regimen included people who contracted hep C within the previous 12 months.